Inhibition of thrombin receptor signaling on α-smooth muscle actin + CD34 + progenitors leads to repair after murine immune vascular injury

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 32, Issue 1, 2012, Pages 42-49

  Chen, Daxin ^a   Shrivastava, Seema ^a,b   Ma, Liang ^a   Tham, El Li ^a   Abrahams, Joel ^b   Coe, J David ^b   Scott, Diane ^b   Lechler, Robert I ^a   McVey, John H ^c   Dorling, Anthony ^a  

^a GUY S HOSPITAL   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c THROMBOSIS RESEARCH INSTITUTE   (United Kingdom)

Author keywords

coagulation; immune system; thrombin; transplantation; vascular biology

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CD31 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; PROTEINASE ACTIVATED RECEPTOR 1; THROMBIN RECEPTOR; TISSUE FACTOR PATHWAY INHIBITOR; VASCULOTROPIN RECEPTOR 2;

ALLOTRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; BLOOD VESSEL INJURY; BLOOD VESSEL TRANSPLANTATION; C57BL 6 MOUSE; CELL HYPERPLASIA; CELL LINEAGE; CELL MOTILITY; CONTROLLED STUDY; ENDOTHELIUM; GRAFT RECIPIENT; HUMAN; IMMUNE DEFICIENCY; INTRACELLULAR SIGNALING; MOUSE; MYELOID PROGENITOR CELL; NEOINTIMA; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

ACTINS; ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD34; AORTA; CAROTID ARTERY INJURIES; HUMANS; LIPOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MYOBLASTS, SMOOTH MUSCLE; NEOINTIMA; RECEPTOR, PAR-1; RECEPTORS, THROMBIN; SIGNAL TRANSDUCTION; WOUND HEALING;

EID: 83655184807     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.111.239046     Document Type: Article

References (36)

1. Cuffy MC, Silverio AM, Qin L, Wang Y, Eid R, Brandacher G, Lakkis FG, Fuchs D, Pober JS, Tellides G. Induction of indoleamine 2,3-dioxygenase in vascular smooth muscle cells by interferon-γcontributes to medial immunoprivilege. J Immunol. 2007;179:5246-5254.
2. Ensminger SM, Witzke O, Spriewald BM, Morrison K, Morris PJ, Rose ML, Wood KJ. CD8+T cells contribute to the development of transplant arteriosclerosis despite CD154 blockade. Transplantation. 2000;69: 2609-2612. (Pubitemid 30482029)
3. Rao DA, Tracey KJ, Pober JS. IL-1αand IL-1βare endogenous mediators linking cell injury to the adaptive alloimmune response. J Immunol. 2007;179:6536-6546.
4. Tellides G, Pober JS. Interferon-γaxis in graft arteriosclerosis. Circ Res. 2007;100:622-632.
5. Shimizu K, Sugiyama S, Aikawa M, Fukumoto Y, Rabkin E, Libby P, Mitchell RN. Host bone-marrow cells are a source of donor intimal smooth-muscle-like cells in murine aortic transplant arteriopathy. Nat Med. 2001;7:738-741. (Pubitemid 32588032)
6. Tanaka K, Sata M, Hirata Y, Nagai R. Diverse contribution of bone marrow cells to neointimal hyperplasia after mechanical vascular injuries. Circ Res. 2003;93:783-790. (Pubitemid 37288674)
7. Xu Q. Mouse models of arteriosclerosis: from arterial injuries to vascular grafts. Am J Pathol. 2004;165:1-10. (Pubitemid 38821809)
8. Iwata H, Manabe I, Fujiu K, Yamamoto T, Takeda N, Eguchi K, Furuya A, Kuro-o M, Sata M, Nagai R. Bone marrow-derived cells contribute to vascular inflammation but do not differentiate into smooth muscle cell lineages. Circulation. 2010;122:2048-2057.
9. Chen D, Weber M, Shiels PG, Dong R, Webster Z, McVey JH, Kemball-Cook G, Tuddenham EG, Lechler RI, Dorling A. Post-injury vascular intimal hyperplasia in mice is completely inhibited by CD34+bone marrow-derived progenitor cells expressing membrane-tethered anticoagulant fusion proteins. J Thromb Haemost. 2006;4:2191-2198. (Pubitemid 44400297)
10. Chen D, Abrahams JM, Smith LM, McVey JH, Lechler RI, Dorling A. Regenerative repair after endoluminal injury in mice with specific antagonism of protease activated receptors on CD34+vascular progenitors. Blood. 2008;111:4155-4164.
11. Chen D, Dorling A. Critical roles for thrombin in acute and chronic inflammation. J Thromb Haemost. 2009;7(suppl 1):122-126.
12. Clarke HM, Shrivastava S, Motterlini R, Sawle P, Chen D, Dorling A. Donor HO-1 expression inhibits intimal hyperplasia in unmanipulated graft recipients: a potential role for CD8+T-cell modulation by carbon monoxide. Transplantation. 2009;88:653-661.
13. de Boer J, Williams A, Skavdis G, Harker N, Coles M, Tolaini M, Norton T, Williams K, Roderick K, Potocnik AJ, Kioussis D. Transgenic mice with hematopoietic and lymphoid specific expression of Cre. Eur J Immunol. 2003;33:314-325. (Pubitemid 36267595)
14. Connolly AJ, Ishihara H, Kahn ML, Farese RV Jr, Coughlin SR. Role of the thrombin receptor in development and evidence for a second receptor. Nature. 1996;381:516-519.
15. Golshayan D, Jiang S, Tsang J, Garin MI, Mottet C, Lechler RI. In vitro-expanded donor alloantigen-specific CD4+CD25+regulatory T cells promote experimental transplantation tolerance. Blood. 2007;109: 827-835. (Pubitemid 46105988)
16. Lutz MB, Kukutsch N, Ogilvie AL, Rossner S, Koch F, Romani N, Schuler G. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods. 1999;223:77-92. (Pubitemid 29096240)
17. Hu Y, Davison F, Zhang Z, Xu Q. Endothelial replacement and angiogenesis in arteriosclerotic lesions of allografts are contributed by circulating progenitor cells. Circulation. 2003;108:3122-3127. (Pubitemid 38031802)
18. Grandaliano G, Di Paolo S, Monno R, Stallone G, Ranieri E, Pontrelli P, Gesualdo L, Schena FP. Protease-activated receptor 1 and plasminogen activator inhibitor 1 expression in chronic allograft nephropathy: the role of coagulation and fibrinolysis in renal graft fibrosis. Transplantation. 2001;72:1437-1443. (Pubitemid 33015772)
19. Holschermann H, Bohle RM, Zeller H, Schmidt H, Stahl U, Fink L, Grimm H, Tillmanns H, Haberbosch W. In situ detection of tissue factor within the coronary intima in rat cardiac allograft vasculopathy. Am J Pathol. 1999;154:211-220. (Pubitemid 29031628)
20. Yamani MH, Masri CS, Ratliff NB, Bond M, Starling RC, Tuzcu EM, McCarthy PM, Young JB. The role of vitronectin receptor (αvβ3) and tissue factor in the pathogenesis of transplant coronary vasculopathy. J Am Coll Cardiol. 2002;39:804-810. (Pubitemid 34185327)
21. Yen MH, Pilkington G, Starling RC, Ratliff NB, McCarthy PM, Young JB, Chisolm GM, Penn MS. Increased tissue factor expression predicts development of cardiac allograft vasculopathy. Circulation. 2002;106: 1379-1383. (Pubitemid 35013042)
22. Holschermann H, Bohle RM, Schmidt H, Zeller H, Fink L, Stahl U, Grimm H, Tillmanns H, Haberbosch W. Hirudin reduces tissue factor expression and attenuates graft arteriosclerosis in rat cardiac allografts. Circulation. 2000;102:357-363. (Pubitemid 30457589)
23. Vu TK, Hung DT, Wheaton VI, Coughlin SR. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell. 1991;64:1057-1068. (Pubitemid 121001193)
24. Nystedt S, Emilsson K, Wahlestedt C, Sundelin J. Molecular cloning of a potential proteinase activated receptor. Proc Natl Acad Sci USA. 1994;91:9208-9212. (Pubitemid 24297883)
25. Ishihara H, Connolly AJ, Zeng D, Kahn ML, Zheng YW, Timmons C, Tram T, Coughlin SR. Protease-activated receptor 3 is a second thrombin receptor in humans. Nature. 1997;386:502-506. (Pubitemid 27164077)
26. Shrivastava S, McVey JH, Dorling A. The interface between coagulation and immunity. Am J Transplant. 2007;7:499-506. (Pubitemid 46376437)
27. Coughlin SR. Thrombin signalling and protease-activated receptors. Nature. 2000;407:258-264.
28. Raisanen-Sokolowski A, Glysing-Jensen T, Koglin J, Russell ME. Reduced transplant arteriosclerosis in murine cardiac allografts placed in interferon-γknockout recipients. Am J Pathol. 1998;152:359-365. (Pubitemid 28106381)
29. Tellides G, Tereb DA, Kirkiles-Smith NC, Kim RW, Wilson JH, Schechner JS, Lorber MI, Pober JS. Interferon-γelicits arteriosclerosis in the absence of leukocytes. Nature. 2000;403:207-211.
30. Wang Y, Bai Y, Qin L, Zhang P, Yi T, Teesdale SA, Zhao L, Pober JS, Tellides G. Interferon-γinduces human vascular smooth muscle cell proliferation and intimal expansion by phosphatidylinositol 3-kinase dependent mammalian target of rapamycin raptor complex 1 activation. Circ Res. 2007;101:560-569. (Pubitemid 351325873)
31. Xu Q. Stem cells and transplant arteriosclerosis. Circ Res. 2008;102: 1011-1024. (Pubitemid 351667855)
32. Daniel JM, Bielenberg W, Stieger P, Weinert S, Tillmanns H, Sedding DG. Time-course analysis on the differentiation of bone marrow-derived progenitor cells into smooth muscle cells during neointima formation. Arterioscler Thromb Vasc Biol. 2010;30:1890-1896.
33. Daniel JM, Sedding DG. Circulating smooth muscle progenitor cells in arterial remodeling. J Mol Cell Cardiol. 2011;50:273-279.
34. Coffelt SB, Lewis CE, Naldini L, Brown JM, Ferrara N, De Palma M. Elusive identities and overlapping phenotypes of proangiogenic myeloid cells in tumors. Am J Pathol. 2010;178:1564-1576.
35. Sakao S, Taraseviciene-Stewart L, Cool CD, Tada Y, Kasahara Y, Kurosu K, Tanabe N, Takiguchi Y, Tatsumi K, Kuriyama T, Voelkel NF. VEGF-R blockade causes endothelial cell apoptosis, expansion of surviving CD34+precursor cells and transdifferentiation to smooth muscle-like and neuronal-like cells. FASEB J. 2007;21:3640-3652. (Pubitemid 350075152)
36. Zeiffer U, Schober A, Lietz M, Liehn EA, Erl W, Emans N, Yan ZQ, Weber C. Neointimal smooth muscle cells display a proinflammatory phenotype resulting in increased leukocyte recruitment mediated by P-selectin and chemokines. Circ Res. 2004;94:776-784. (Pubitemid 38451739)